Clinical experience with tamoxifen in encapsulating peritoneal sclerosis

Peritoneal Dialysis International

Volumn 26, Issue 2, 2006, Pages 183-184

  Wong, Christopher F ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID; TAMOXIFEN;

ARTICLE; DRUG UTILIZATION; EXPERIENCE; HUMAN; KIDNEY FAILURE; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PERITONEAL SCLEROSIS; PRIORITY JOURNAL; RECURRENT INFECTION; RISK ASSESSMENT; RISK FACTOR; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT DURATION; TREATMENT OUTCOME; ULTRAFILTRATION; FEMALE; MALE; NOTE; PATHOLOGY; PERITONEUM; SCLEROSIS;

FEMALE; HUMANS; MALE; PERITONEAL DIALYSIS; PERITONEAL DISEASES; PERITONEUM; SCLEROSIS; TAMOXIFEN;

EID: 33747086652     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080602600210     Document Type: Article

References (8)

1. Wong CF, Beshir S, Khalil A, Pai P, Ahmad R. Successful treatment of encapsulating peritoneal sclerosis with azathioprine and prednisolone. Perit Dial Int 2005; 25: 285-94.
2. Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. Perit Dial Int 2000; 20(Suppl 4):S43-55.
3. Eltoum MA, Wright S, Atchley J, Mason JC. Four consecutive cases of peritoneal dialysis-related encapsulating peritoneal sclerosis treated successfully with tamoxifen. Perit Dial Int 2006; 26:203-6.
4. Allaria PM, Giangrande A, Gandini E, Pisoni IB. Continuous ambulatory peritoneal dialysis and sclerosing encapsulating peritonitis: tamoxifen as a new therapeutic agent? J Nephrol 1999; 12:395-7.
5. Turner MW, Holleman JH, Charlotte NC. Successful therapy of sclerosing peritonitis. Semin Dial 1992; 5:316.
6. Pollock CA. Bloody ascites in patient after transfer from peritoneal dialysis to hemodialysis. Semin Dial 2003; 16: 406-10.
7. Evrenkaya TR, Atasoyu EM, Unver S. Basekim C, Baloglu H, Tulbek MY. Corticosteroid and tamoxifen therapy in sclerosing encapsulating peritonitis in a patient on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2004; 19:2423-4.
8. del Peso G, Bajo AM, Gil F, Aguilera A, Ros S, Costero O, et al. Clinical experience with tamoxifen in peritoneal fibrosing syndromes. Adv Perit Dial 2003; 19:32-5.